WallStreetZenWallStreetZen

NYSE: PFE
Pfizer Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnershipStatistics

Analyst price target for PFE

Based on 9 analysts offering 12 month price targets for Pfizer Inc.
Min Forecast
$38.00+13.03%
Avg Forecast
$48.00+42.77%
Max Forecast
$75.00+123.08%

Should I buy or sell PFE stock?

Based on 9 analysts offering ratings for Pfizer Inc.
Buy
Strong Buy
3 analysts 33.33%
Buy
1 analysts 11.11%
Hold
5 analysts 55.56%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PFE stock forecasts and price targets.

PFE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Bottom 2%
2
Strong BuyReiterates$75.00+123.08%2023-09-18
Truist Securities
Bottom 5%
5
Strong BuyReiterates$62.00+84.41%2023-09-13
Morgan Stanley
Top 7%
94
HoldMaintains$40.00+18.98%2023-08-02
BMO Capital
Bottom 41%
41
BuyMaintains$44.00+30.87%2023-08-02
HSBC
Top 34%
67
Strong BuyInitiates Coverage On$50.00+48.72%2023-07-14Find out why
Barclays
Top 19%
82
HoldMaintains$38.00+13.03%2023-07-11Find out why
Credit Suisse
Top 20%
81
HoldDowngrades$40.00+18.98%2023-06-29Find out why
Daiwa Capital
Bottom 50%
50
HoldDowngrades$38.00+13.03%2023-05-11
Bank of America
Bottom 7%
7
HoldMaintains$45.00+33.85%2023-04-21Find out why

1 of 1

Forecast return on equity

Is PFE forecast to generate an efficient return?
Company
21.33%
Industry
14.06%
Market
28.66%
PFE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PFE forecast to generate an efficient return on assets?
Company
9.59%
Industry
5.45%
PFE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PFE earnings per share forecast

What is PFE's earnings per share in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$3.33-12.6%
Avg 2 year Forecast
$3.22-15.49%
Avg 3 year Forecast
$3.41-10.5%
PFE's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PFE revenue forecast

What is PFE's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$66.5B-14.72%
Avg 2 year Forecast
$66.2B-15.11%
Avg 3 year Forecast
$66.4B-14.79%
PFE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PFE earnings growth forecast

How is PFE forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
-4.34%
Industry
33.23%
Market
20.3%
PFE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PFE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PFE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PFE revenue growth forecast

How is PFE forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
-5.24%
Industry
3.44%
Market
8.17%
PFE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PFE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PFE vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
PFE$33.62$48.00+42.77%Buy
AZN$67.96$81.50+19.92%Strong Buy
NVS$103.58N/AN/A
AMGN$271.46$262.40-3.34%Buy
SNY$55.20$60.00+8.70%Strong Buy
View Top General Drug Manufacturer Stocks

Pfizer Stock Forecast FAQ

Is Pfizer Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: PFE) stock is to Buy PFE stock.

Out of 9 analysts, 3 (33.33%) are recommending PFE as a Strong Buy, 1 (11.11%) are recommending PFE as a Buy, 5 (55.56%) are recommending PFE as a Hold, 0 (0%) are recommending PFE as a Sell, and 0 (0%) are recommending PFE as a Strong Sell.

If you're new to stock investing, here's how to buy Pfizer stock.

What is PFE's earnings growth forecast for 2023-2025?

(NYSE: PFE) Pfizer's forecast annual earnings growth rate of -4.34% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 33.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.3%.

Pfizer's earnings in 2023 is $21,472,000,000.On average, 10 Wall Street analysts forecast PFE's earnings for 2023 to be $18,801,045,368, with the lowest PFE earnings forecast at $18,292,909,007, and the highest PFE earnings forecast at $19,591,479,708. On average, 10 Wall Street analysts forecast PFE's earnings for 2024 to be $18,179,989,815, with the lowest PFE earnings forecast at $16,486,201,944, and the highest PFE earnings forecast at $20,777,131,218.

In 2025, PFE is forecast to generate $19,252,722,134 in earnings, with the lowest earnings forecast at $17,615,393,858 and the highest earnings forecast at $21,398,186,770.

What is PFE's revenue growth forecast for 2023-2025?

(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -5.24% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 3.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.17%.

Pfizer's revenue in 2023 is $77,944,000,000.On average, 6 Wall Street analysts forecast PFE's revenue for 2023 to be $375,272,134,557,867, with the lowest PFE revenue forecast at $368,121,306,570,039, and the highest PFE revenue forecast at $383,208,535,714,305. On average, 6 Wall Street analysts forecast PFE's revenue for 2024 to be $373,557,733,288,477, with the lowest PFE revenue forecast at $338,795,306,147,806, and the highest PFE revenue forecast at $395,781,765,857,000.

In 2025, PFE is forecast to generate $374,998,316,810,641 in revenue, with the lowest revenue forecast at $334,814,712,688,331 and the highest revenue forecast at $408,406,131,455,520.

What is PFE's forecast return on assets (ROA) for 2023-2026?

(NYSE: PFE) forecast ROA is 9.59%, which is higher than the forecast US Drug Manufacturers - General industry average of 5.45%.

What is PFE's Price Target?

According to 9 Wall Street analysts that have issued a 1 year PFE price target, the average PFE price target is $48.00, with the highest PFE stock price forecast at $75.00 and the lowest PFE stock price forecast at $38.00.

On average, Wall Street analysts predict that Pfizer's share price could reach $48.00 by Sep 18, 2024. The average Pfizer stock price prediction forecasts a potential upside of 42.77% from the current PFE share price of $33.62.

What is PFE's Earnings Per Share (EPS) forecast for 2023-2025?

(NYSE: PFE) Pfizer's current Earnings Per Share (EPS) is $3.81. On average, analysts forecast that PFE's EPS will be $3.33 for 2023, with the lowest EPS forecast at $3.24, and the highest EPS forecast at $3.47. On average, analysts forecast that PFE's EPS will be $3.22 for 2024, with the lowest EPS forecast at $2.92, and the highest EPS forecast at $3.68. In 2025, PFE's EPS is forecast to hit $3.41 (min: $3.12, max: $3.79).

What is PFE's forecast return on equity (ROE) for 2023-2026?

(NYSE: PFE) forecast ROE is 21.33%, which is considered strong.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.